COVID-19 Multifamily

RiskNomics (through its accredited and independent laboratory partners) is now able to offerenvironmental surface testing for SARS-CoV-2 (COVID-19)for our clients. This testing will evaluate the effectiveness of the products and processes used to decontaminate suspect surfaces.

Testing will confirm the presence/absence of the RNA genetic signature of the SARS-CoV-2 virus by swab samples from possibly contaminated environmental surfaces. While positive sample results indicate presence of the viral genetic SARS-CoV-2 nucleic material, test results may not definitively rule out the presence of other viral/bacterial contamination. Testing will also not indicate if the virus is still infectious, but only its presence/absence.

Note: Due to a current shortage of viral transport swabs, there may be some delays in testing availability turnaround times.

Industry leading expertise from the environmental and healthcare fields, helping you economically manage risks. Industry leading expertise from the environmental and healthcare fields, helping you economically manage risks.